We asked medicine makers around the world to tell us how their professional and personal lives have changed during the ongoing COVID-19 crisis.

A repurposed drug could help improve immunotherapy response rates.

How can artificial intelligence and deep-learning platforms be used to combat malaria?

A dispersible tablet could open up treatment options for pediatric patients, according to Harmony Grages, Chief Medical Officer at ViiV Healthcare.

Can we reverse the effect of the ageing process on the immune system?

Announcing the grand winner of The Medicine Maker 2019 Innovation Awards.

Matt Ling and Andrew Parker, both at Catalent, walks us through the most important developments in pediatric drug manufacturing.

A clinical trial tracker aims to encourage international collaboration on COVID-19 drug development.

Researchers from the University of Illinois hope to design medical materials with the same surface traits as the compounds found on cicada wings.

Technology transfer can be a challenge with any drug product. Even greater vigilance is needed with more complex formulations, like LNP-based drugs.